Taken together, these findings indicate that SGOL1 promotes the malignant progression of ccRCC by constructing an immunosuppressive microenvironment, increasing the infiltration of Treg cells, and upregulating the expression of immune checkpoint inhibitors. Here, SGO1 is linked to nonpapillary renal cell carcinoma.